Milea Timbergen

201 References 1 . Müller J. Ueber den feinern bau und die formen der krankhaften geschwülste 1838. 2 . Macfarlane J. Clinical reports of the Surgical Practice of the Glasgow, Royal Infirmary. Rotertson, D., Ed., 1832:63. 3 . Fletcher CDM. WHO classification of tumours of soft tissue and bone. Lyon: IARC, 2013. 4 . Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005; 18(1):68-74. 5 . Colombo C, Miceli R, Le Pechoux C, et al. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. European Journal of Cancer 2015:186-192. 6 . van Broekhoven DL, Grunhagenl DJ, van Dalen T, et al. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention. BMC Cancer 2016; 16:686. 7 . Gronchi A. NCT02547831 - Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients ClinicalTrials.gov Available from: https://clinicaltrials.gov/ct2/show/NCT02547831?cond=NCT02547831&rank=1. Accessed 25 January 2019. 8 . Bonvalot S. NCT01801176 - Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression ClinicalTrials.gov Available from: https://clinicaltrials.gov/ct2/show/NCT01801176?cond=NCT01801176&rank=1. Accessed 25 January 2019, 9 . Verhoef C. NTR4714 - GRAFITI study: A prospective registration study on growth behavior of aggressive fibromatosis without therapeutic intervention” Nederlands Trial Register Available from: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4714. Accessed 25 January 2019 10 . Kasper B, Baumgarten C, Garcia J, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol 2017; 28(10):2399-2408. 11 . Reitamo JJ. The desmoid tumor. IV. Choice of treatment, results, and complications. Archives of Surgery 1983; 118(11):1318-1322. 12 . Bonvalot S, Ternes N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol 2013; 20(13):4096-102. 13 . Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor. Not a benign disease. Arch Surg 1989; 124(2):191-6. 14 . Crago AM, Denton B, Mezhir JJ, et al. A prognostic nomogram for prediction of recurrence following surgical resection of desmoid tumors. Journal of Clinical Oncology 2012; 30(15). 15 . Crago AM, Chmielecki J, Rosenberg M, et al. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes Chromosomes Cancer 2015; 54(10):606-615. 16 . De Marchis ML, Tonelli F, Quaresmini D, et al. Desmoid Tumors in Familial Adenomatous Polyposis. Anticancer Res 2017(37):3357-336. 17 . Heiskanen I, Jarvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996; 11(4):157-62. 18 . Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001; 95(2):102-7. 19 . Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008; 173(5):1518-27. 20 . Mullen JT, DeLaney TF, Rosenberg AE, et al. β-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist 2013; 18(9):1043-1049. 21 . Domont J, Benard J, Lacroix L, et al. Detection of beta-catenin mutations in primary extra-abdominal fibromatosis (EAF): An ancillary diagnostic tool. Journal of Clinical Oncology 2008; 26:10518-10518. 7